Community Health Center Drug Pricing Protection Act
To amend title III of the Public Health Service Act to ensure that Federally-qualified health centers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase.
HB7391, known as the Community Health Center Drug Pricing Protection Act, aims to ensure that Federally-qualified health centers do not have to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase. This bill is designed to protect these centers from higher drug costs, which could affect the affordability and availability of healthcare services they provide.
The bill would primarily impact health centers and the patients they serve. By capping drug prices, the bill seeks to lower healthcare costs for these centers, potentially leading to more affordable services and better health outcomes for patients. The bill has been introduced and referred to the House Committee on Energy and Commerce, marking the first steps in its legislative journey.
As of February 5, 2026, HB7391 has been introduced in the House and referred to the House Committee on Energy and Commerce. This is the latest update on the bill's progress, indicating that it is in the early stages of the legislative process.
